olumiant
eli lilly nederland b.v. - baricitinib - niveltulehdus, nivelreuma - immunosuppressantit - rheumatoid arthritisbaricitinib is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). olumiantia voidaan käyttää monoterapiana tai yhdistelmänä metotreksaatin kanssa. atopic dermatitisolumiant is indicated for the treatment of moderate to severe atopic dermatitis in adult and paediatric patients 2 years of age and older who are candidates for systemic therapy. alopecia areatabaricitinib is indicated for the treatment of severe alopecia areata in adult patients (see section 5. juvenile idiopathic arthritisbaricitinib is indicated for the treatment of active juvenile idiopathic arthritis in patients 2 years of age and older who have had an inadequate response or intolerance to one or more prior conventional synthetic or biologic dmards:- polyarticular juvenile idiopathic arthritis (polyarticular rheumatoid factor positive [rf+] or negative [rf-], extended oligoarticular),- enthesitis related arthritis, and- juvenile psoriatic arthritis. baricitinib may be used as monotherapy or in combination with methotrexate.
teysuno
nordic group b.v. - tegafur, gimeracil, oteracil - mahalaukun kasvaimet - antineoplastiset aineet - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.
zavicefta
pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - systeemiset bakteerilääkkeet, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. on otettava huomioon viralliset ohjeet antibioottien tarkoituksenmukaisesta käytöstä.
maviret
abbvie deutschland gmbh co. kg - glecaprevir, pibrentasvir - hepatiitti c, krooninen - antiviraalit systeemiseen käyttöön - maviret is indicated for the treatment of chronic hepatitis c virus (hcv) infection in adults and children aged 3 years and older. maviret coated granules is indicated for the treatment of chronic hepatitis c virus (hcv) infection in children 3 years and older.
daktarin 2 % emulsiovoide
mcneil / jntl consumer health (finland) oy - miconazole nitrate - emulsiovoide - 2 % - mikonatsoli
daktarin 2 % puuteri
mcneil / jntl consumer health (finland) oy - miconazole nitrate - puuteri - 2 % - mikonatsoli
daktacort 20 mg/g + 10 mg/g emulsiovoide
mcneil / jntl consumer health (finland) oy - hydrocortisone, miconazole nitrate - emulsiovoide - 20 mg/g + 10 mg/g - imidatsolit/triatsolit yhdistelmävalmisteina kortikosteroidien kanssa
gyno-daktarin 400 mg emätinpuikko, kapseli, pehmeä
mcneil, a division of janssen-cilag oy - miconazole nitrate - emätinpuikko, kapseli, pehmeä - 400 mg - mikonatsoli
konact 20 mg/g shampoo
sanoswiss uab - ketoconazole - shampoo - 20 mg/g - ketokonatsoli
dolpac vet tabletti
vetoquinol s.a. - pyrantel embonate, oxantel embonate, praziquantel - tabletti - pratsikvanteeli